| China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency |
TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that the Company received a written notification (the “Compliance Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated March 13, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”) and the matter is closed. |
globenewswire.com |
2025-03-17 10:30:00 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals, Inc. Announces Share Consolidation |
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-8, effective on February 25, 2025 (the “Share Consolidation”). The Company's ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on February 25, 2025. Upon the market opening on February 25, 2025, the Company's ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “SXTC” with the new CUSIP number G2161P157. |
globenewswire.com |
2025-02-21 14:35:00 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency |
Jiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on October 3, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). |
globenewswire.com |
2024-10-07 20:15:00 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule |
TAIZHOU, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced that on October 19, 2023, NASDAQ notified us that it has determined that for the 10 consecutive business days, from October 5, 2023 to October 13, 2023, the closing bid price of the Company's ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and NASDAQ has closed this matter. |
globenewswire.com |
2023-10-26 20:05:00 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split |
Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023 Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023 |
globenewswire.com |
2023-10-04 12:30:00 |
Czytaj oryginał (ang.) |
| Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today? |
China SXT Pharmaceuticals (NASDAQ: SXTC ) stock is heading higher on Thursday even without any news from the pharmaceutical company. There's no recent news from China SXT Pharmaceuticals that explains today's rally. |
investorplace.com |
2023-09-07 11:55:49 |
Czytaj oryginał (ang.) |
| Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today? |
China SXT Pharmaceuticals (NASDAQ: SXTC ) stock is rocketing higher on Monday despite a lack of news from the pharmaceutical company. The Chinese pharmaceutical company hasn't released any new news or filings that explain today's rise. |
investorplace.com |
2023-08-21 11:53:50 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals (SXTC) Stock: 1-For-20 Reverse Split Goes Into Effect |
A 1-for-20 reverse split of the China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) stock has gone into effect. These are the details. |
pulse2.com |
2022-05-19 13:11:28 |
Czytaj oryginał (ang.) |
| Best Penny Stocks, How To Buy & Strategies for Beginners |
Are these strategies on your list for buying penny stocks next month? The post Best Penny Stocks, How To Buy & Strategies for Beginners appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com. |
pennystocks.com |
2022-04-24 15:30:00 |
Czytaj oryginał (ang.) |
| Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today? |
SXTC stock is soaring higher on no company-specific news. Positive developments between the U.S. and China may be fueling gains. |
investorplace.com |
2022-03-29 16:18:18 |
Czytaj oryginał (ang.) |
| Trading Penny Stocks? Top Stock Market News for March 29th, 2022 |
Here's what you need to know about trading penny stocks on March 29th The post Trading Penny Stocks? Top Stock Market News for March 29th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com. |
pennystocks.com |
2022-03-29 13:28:22 |
Czytaj oryginał (ang.) |
| Best Penny Stocks To Buy? 5 Explosive Stocks Under $1 To Watch Now |
Penny Stocks Under $1 To Watch This Week. The post Best Penny Stocks To Buy? |
pennystocks.com |
2022-03-23 17:19:31 |
Czytaj oryginał (ang.) |
| Best Penny Stocks To Buy? 5 China Stocks To Watch Right Now |
China penny stocks to watch right now The post Best Penny Stocks To Buy? 5 China Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com. |
pennystocks.com |
2022-03-16 12:00:46 |
Czytaj oryginał (ang.) |
| China SXT Pharmaceuticals Stock (SXTC): Why The Price Substantially Went Down Today |
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) fell by over 45% pre-market today. This is why it happened. |
pulse2.com |
2022-01-18 08:45:15 |
Czytaj oryginał (ang.) |
| SXTC Stock Increases Over 40% Intraday: Details You Should Know |
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) increased by over 40% during intraday trading. These are some details you should know. |
pulse2.com |
2021-07-16 16:56:30 |
Czytaj oryginał (ang.) |
| 4 ‘High Volume' Penny Stocks to Watch in July 2021 |
These 3 Penny Stocks to Watch Pushed Up Substantially Today; Worth it or Not? The post 4 ‘High Volume' Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com. |
pennystocks.com |
2021-07-16 16:13:02 |
Czytaj oryginał (ang.) |
| SXTC Stock Price Increased Over 20% Pre-Market: Why It Happened |
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has increased by over 20% pre-market. This is why it happened. |
pulse2.com |
2021-03-29 09:16:42 |
Czytaj oryginał (ang.) |
| SXTC Stock Price Increases Over 200% Pre-Market: Why It Happened |
The stock price of China SXT Pharmaceuticals (NASDAQ: SXTC) is trading at over 200% pre-market. This is why it happened. |
pulse2.com |
2021-02-22 08:02:10 |
Czytaj oryginał (ang.) |
| SXTC Stock Price Increases Over 10% Pre-Market: Why It Happened |
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) is trading at over 10% pre-market today. This is why it happened. |
pulse2.com |
2021-02-08 08:20:38 |
Czytaj oryginał (ang.) |
| Is China SXT Pharmaceuticals, Inc. (SXTC) A Good Stock To Buy? |
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don't always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let's take a look at the recent hedge fund activity surrounding China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC). |
insidermonkey.com |
2020-11-26 22:16:17 |
Czytaj oryginał (ang.) |